Community Pharmacy-based Point-of-Care Testing Certificate Program

Updated Program Information

The National Association of Chain Drug Stores is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The home study portion of the updated 2018 program is approved for 16 contact hours and the live training is approved for 4 contact hours of continuing pharmacy education credit. Credit is only awarded for completion of the entire 20 contact hour program. Credit must be claimed within 60 days of completing the program.

Community Pharmacy-based Point-of-Care Testing Certificate ACPE University Activity #0206-0000-17-012-B04-P.

Activity Type: Practice-based

Target Audience: Pharmacists in all practice settings

Release Date: January 2, 2018

Expiration Date: January 2, 2021

Target Audience

This course provides community pharmacists and members of academia, industry and government with the skills necessary to develop a testing program for influenza, Group A streptococcus, HIV and hepatitis C. 

Claiming Credit

Continuing pharmacy education (CPE) credit will be awarded for the certificate training course only. This is a practice-based activity and is primarily constructed to instill, expand or enhance practice competencies through the systematic achievement of specified knowledge, skills, attitudes and perfomance behaviors.

Successful completion of the live seminar component involves passing the final exam with a grade of 70 percent or higher and demonstrating proficiency in diagnostic testing techniques. Successful completion of this component will result in 4.0 contact hours of continuing pharmacy education credit. Successful completion of the self-study component involves passing the self-study assessment questions with a grade of 70 percent or higher and will result in 16.0 contact hours of continuing pharmacy education. Attendance and participation are required before obtaining CPE credit. Partial credit will not be awarded.

CPE Monitor, a national, collaborative effort by ACPE and the National Association of Boards of Pharmacy (NABP) to provide an electronic system for pharmacists to track their completed PCE credits, went into effect on Jan. 1, 2013. NACDS, as an ACPE-accredited provider, is required to report pharmacist CPE credit using this new tracking system. Pharmacist participants must provide their NABP e-Profile identification number and date of birth (in MMDD format) when they register for a CPE activity. It will be the responsibility of the pharmacist to provide the correct information (i.e., e-Profile identification number and date of birth in MMDD format). If this information is not provided, NABP and ACPE prohibit NACDS from issuing CPE credit. Online access to their inventory of completed credits will allow pharmacists to easily monitor their compliance with CPE requirements and print statements of credit. Therefore, NACDS will not provide printed statements of credit to pharmacists. If you have not signed up for CPE Monitor, please go to MyCPEMonitor.net.

Learning Objectives

The pharmacist who completes the home-study and live components of this Point-of-Care Testing Certificate Program should be able to:

  • Identify at least 3 opportunities for expanding patient-centered services in the community pharmacy setting, using point of care testing
  • Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies
  • Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, Cervical Lymph Node Inspection, Body Temperature
  • Describe and perform the following specimen collections used in point of care testing:Throat swab, Oral fluid collection, Nasal swab, Finger stick
  • Identify characteristics of the four exemplar infectious diseases (influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate therapy, Point-of-Care testing
  • Define and contrast the following terms as they relate to point-of-care testing in community pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose
  • Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance
  • Apply all information to patient-specific cases based on common community pharmacy-based patient interactions

© 2018 National Association of Chain Drug Stores, Inc.  All rights reserved.